Mercy Regional Cancer Center at Mercy Medical Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1995
NCT00276731
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1995

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5